BamSEC and AlphaSense Join Forces
Learn More

Life Technologies Corp

Indentures Filter

EX-4.2
from 8-K 31 pages Recitals of the Company
12/34/56
EX-4.2
from 8-K 40 pages First Supplemental Indenture
12/34/56
EX-4.1
from 8-K 89 pages Life Technologies Corporation, as the Company and U.S. Bank National Association, as Trustee Indenture Dated as of February 19, 2010 Senior Debt Securities Certain Sections of This Indenture Relating to Sections 310 Through 318, Inclusive, of the Trust Indenture Act of 1939
12/34/56
EX-4.1
from S-3ASR 89 pages Life Technologies Corporation, as the Company and U.S. Bank National Association, as Trustee Indenture Dated as of February [ ], 2010 Senior Debt Securities Certain Sections of This Indenture Relating to Sections 310 Through 318, Inclusive, of the Trust Indenture Act of 1939
12/34/56
EX-4.1
from 8-K 16 pages $350,000,000 3.25% Convertible Senior Notes Due 2025 Registration Rights Agreement Dated as of June 20, 2005 by and Among Invitrogen Corporation and Ubs Securities LLC and Banc of America Securities LLC
12/34/56
EX-4.11
from 10-K 86 pages Invitrogen Corporation 2% Convertible Senior Notes Due 2023 Indenture Dated as of December 14, 2004 U.S. Bank National Association as Trustee
12/34/56
EX-4.10
from 10-K 85 pages Invitrogen Corporation 1.5% Convertible Senior Notes Due 2024 Indenture Dated as of December 14, 2004 U.S. Bank National Association as Trustee
12/34/56
EX-4.4
from S-4/A 84 pages Invitrogen Corporation 1.5% Convertible Senior Notes Due 2024 Indenture Dated as of December [ ], 2004 U.S. Bank National Association as Trustee
12/34/56
EX-4.3
from S-4/A 85 pages Invitrogen Corporation 2 % Convertible Senior Notes Due 2023 Indenture Dated as of December [ ], 2004 U.S. Bank National Association as Trustee
12/34/56
EX-4.7
from S-4 14 pages Amended and Restated Bylaws of Invitrogen Corporation, a Delaware Corporation Index
12/34/56
EX-4.6
from S-4 6 pages Certificate of Correction Filed to Correct a Certain Error in the Restated Certificate of Incorporation of Invitrogen Corporation C. Series B Preferred Stock
12/34/56
EX-4.5
from S-4 20 pages Restated Certificate of Incorporation of Invitrogen Corporation a Delaware Corporation
12/34/56
EX-4.3
from S-3 31 pages Invitrogen Corporation $450,000,000 Principal Amount 1.5% Convertible Senior Notes Due 2024 Purchase Agreement February 12, 2004 Ubs Securities LLC Bear, Stearns & Co. Inc. 1.5% Convertible Senior Notes Due 2024 Invitrogen Corporation Purchase Agreement
12/34/56
EX-4.9
from 10-Q 88 pages Invitrogen Corporation 1.5% Convertible Senior Notes Due 2024 Indenture Dated as of February 19, 2004 U.S. Bank National Association as Trustee
12/34/56
EX-4.8
from 10-Q 17 pages $517,500,000 1.5% Convertible Senior Notes Due 2024 Registration Rights Agreement Dated as of February 19, 2004 by and Among Invitrogen Corporation and Ubs Securities LLC Bear, Stearns & Co. Inc
12/34/56
EX-4.1
from S-3 98 pages Invitrogen Corporation 2% Convertible Senior Notes Due 2023 Indenture Dated as of August 1, 2003 U.S. Bank National Association as Trustee
12/34/56
EX-4.5
from 10-K405 >50 pages Indenture or similar
12/34/56
EX-4.4
from 10-K405 ~20 pages Indenture or similar
12/34/56
EX-4.1
from S-3 ~5 pages Indenture or similar
12/34/56
EX-4.1
from S-1/A 1 page Indenture or similar
12/34/56